Hot topics in lupus pregnancy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Rheumatology

ISSN

2220-3214

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Rheumatol. Nov 12, 2013; 3(3): 32-39
Published online Nov 12, 2013. doi: 10.5499/wjr.v3.i3.32

Table 6 Medications use during systemic lupus erythematosus pregnancy

Medication	Permitted	Not allowed
Corticosteroids	Prednisolone, Dexamethasone, Betamethasone, Pulses methylprednisolone
Antimalarials	Hydroxychloroquine
Immunosuppressives	Cyclosporine	Cyclophosphamide
	Azathioprine	Methotrexate
	Tacrolimus	Leflunomide
		Mycophenolate mofetil
Anticoagulants	Unfractionated heparin	Warfarin
Anticoagulants	Low-molecular-weight heparin	Acenocumarol
Antiplatelets	Aspirin	Clopidogrel
Antiplatelets	Aspirin	Ticlopidine
Non-steroidal anti-inflammatory drugs and analgesics	NSAIDs (until week 32)	COX-2 inhibitors
Non-steroidal anti-inflammatory drugs and analgesics	Acetaminophen	COX-2 inhibitors
Biologics		Rituximab
Biologics		Belimumab
Miscellaneous	Intravenous immunoglobulin

NSAID: Non-steroidal non steroidal antiinflammatory drugs.

Citation: Cavallasca JA, Costa CA, Maliandi MDR, Musuruana JL. Hot topics in lupus pregnancy. World J Rheumatol 2013; 3(3): 32-39
URL: https://www.wjgnet.com/2220-3214/full/v3/i3/32.htm
DOI: https://dx.doi.org/10.5499/wjr.v3.i3.32

Cavallasca JA, Costa CA, Maliandi MDR, Musuruana JL. Hot topics in lupus pregnancy. World J Rheumatol 2013; 3(3): 32-39 [DOI: 10.5499/wjr.v3.i3.32]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.